new tumour marker gastric cancer date tumour markers gastric cancer unreliable study value new serum marker serum activities carcinoembryonic antigen CEA consecutive series patients gastric cancer results assay stage II disease normal controls CEA differentiation patients positive negative nodes serosa positive negative CEA patients positive negative nodes CEA patients serosa positive negative study specificity cent sensitivities CEA preliminary findings reliable tumour marker disease stage activity gastric cancer Further longitudinal studies full evaluation clinical utility 